Search

Your search keyword '"Goodyear, Carl S."' showing total 378 results

Search Constraints

Start Over You searched for: Author "Goodyear, Carl S." Remove constraint Author: "Goodyear, Carl S."
378 results on '"Goodyear, Carl S."'

Search Results

2. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

3. SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

6. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

8. Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial

10. Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal Metastasis

12. Large-vessel vasculitis

14. BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study

16. BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

18. IĸB Protein BCL3 as a Controller of Osteogenesis and Bone Health

21. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL

22. Low sulfated heparan sulfate mimetic differentially affects repair in immune‐mediated and toxin‐induced experimental models of demyelination

24. Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis.

26. Immunogenicity of SARSCoV2 Third Dose Vaccine Strategies in Immunocompromised Patients with Suboptimal Immunity Following Two Doses (OCTAVE-DUO): An Open-Label, Multi-Centre, Randomised, Controlled Phase III Trial

29. Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration

30. SCIENCE AND SOCIETY: The RA-MAP Consortium: a working model for academia-industry collaboration

33. RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

34. Annexin-A1: the culprit or the solution?

37. A Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity

40. Large-vessel vasculitis

43. Contributors

45. Moderate Exercise Protects Against Joint Disease in a Murine Model of Osteoarthritis

47. Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.

50. The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice

Catalog

Books, media, physical & digital resources